Micro-implant d'acétonide de fluocinolone (ILUVIEN(®)) pour l'oedème maculaire diabétique chronique [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].

Details

Ressource 1Download: BIB_0EDEFD6ACA3B.P001.pdf (1021.60 [Ko])
State: Public
Version: Author's accepted manuscript
Serval ID
serval:BIB_0EDEFD6ACA3B
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Micro-implant d'acétonide de fluocinolone (ILUVIEN(®)) pour l'oedème maculaire diabétique chronique [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
Journal
Journal Français d'Ophtalmologie
Author(s)
Soubrane G., Behar-Cohen F.
ISSN
1773-0597 (Electronic)
ISSN-L
0181-5512
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
38
Number
2
Pages
159-167
Language
french
Notes
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish
Abstract
Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy and may cause severe visual loss. In this article, we examine the pathophysiology of DME and review various treatment options, such as laser photocoagulation, anti-vascular endothelial growth factor (VEGF) receptor antibodies, and steroids including ILUVIEN(®), which is a new sustained-release, non biodegradable, injectable, intravitreal micro-implant containing fluocinolone acetonide. The results of the FAME (Fluocinolone Acetonide in Diabetic Macular Edema) studies, conducted to evaluate the efficacy and safety of ILUVIEN(®) in DME, are discussed.
Keywords
Chronic Disease, Diabetic Retinopathy/complications, Diabetic Retinopathy/drug therapy, Drug Implants, Fluocinolone Acetonide/administration & dosage, Humans, Intravitreal Injections, Macular Edema/drug therapy, Macular Edema/etiology
Pubmed
Web of science
Create date
02/02/2016 10:16
Last modification date
20/08/2019 12:35
Usage data